Advectus ne Nano für unter 4 mio$ Mk....1000% ?

Prof. Kreuter ist ein absolut hohes Tier an der Goethe-Universität an der Uni Frankfurt. Ich denke, dass dies auf ein gewisses Know-How hindeutet!

Scientific Advisory Board:

Dr. Michael Morgan has over 20 years experience in the management and
technical aspects of regulatory toxicology, together with extensive experience in the conduct and reporting of non-clinical toxicology studies for registration of products with the FDA and European regulatory authorities. Dr. Morgan has designed and implemented pre-clinical development plans for a major pharmaceutical company and several biotechnology companies. He has written expert reports for international dossiers supporting European submissions of major pharmaceutical and biotechnology companies, has placed and monitored several toxicology, pharmacology and pharmacokinetic studies and audited many such studies in major contract laboratories in the United States, Canada, Scotland, England and France. Dr. Morgan is an officer and a director of the Company. More...

Dr. Ed Stephen has more than 30 years experience in all aspects of
biopharmaceutical research and development, as well as drug and device
development. He gained postdoctoral training in pharmacology and toxicology at
the University of Alabama Medical School where he lectured in pharmacology.
Following his postdoctoral training, he directed the evolution of the anti-viral drug
development effort for the U.S. Department of Defense. Subsequent to leaving the U.S. Army, Dr. Stephen directed the preclinical toxicology studies for the National Cancer Institute.